Consensus Conference: A reappraisal of Gaucher disease - diagnosis and disease management algorithms

Por Mistry, Pramod K., Cappellini, Maria Domenica, Lukina, Elena, Özsan, Hayri, Pascual, Sara Mach, Rosenbaum, Hanna, Solano, Maria Helena, Spigelman, Zachary, Villarrubia, Jesús, Watman, Nora Patricia, Massenkeil, Gero
Publicado em 2011

Skeletal improvement in patients with Gaucher disease type 1: a phase 2 trial of oral eliglustat

Por Kamath, Ravi S., Lukina, Elena, Watman, Nora, Dragosky, Marta, Pastores, Gregory M., Arreguin, Elsa Avila, Rosenbaum, Hanna, Zimran, Ari, Aguzzi, Rasha, Puga, Ana Cristina, Norfleet, Andrea M., Peterschmitt, M. Judith, Rosenthal, Daniel I.
Publicado em 2014

Improvement in hematological, visceral, and skeletal manifestations of Gaucher disease type 1 with oral eliglustat tartrate (Genz-112638) treatment: 2-year results of a phase 2 stu...

Por Lukina, Elena, Watman, Nora, Arreguin, Elsa Avila, Dragosky, Marta, Iastrebner, Marcelo, Rosenbaum, Hanna, Phillips, Mici, Pastores, Gregory M., Kamath, Ravi S., Rosenthal, Daniel I., Kaper, Mathilde, Singh, Tejdip, Puga, Ana Cristina, Peterschmitt, M. Judith
Publicado em 2010

A phase 2 study of eliglustat tartrate (Genz-112638), an oral substrate reduction therapy for Gaucher disease type 1

Por Lukina, Elena, Watman, Nora, Arreguin, Elsa Avila, Banikazemi, Maryam, Dragosky, Marta, Iastrebner, Marcelo, Rosenbaum, Hanna, Phillips, Mici, Pastores, Gregory M., Rosenthal, Daniel I., Kaper, Mathilde, Singh, Tejdip, Puga, Ana Cristina, Bonate, Peter L., Peterschmitt, M. Judith
Publicado em 2010